Tools / Inside Trading Tracker
Inside Trading Tracker
Track insider trading activity at publicly traded companies to understand how executives are trading their shares.
Boston Scientific Corporation (BSX) Insider Trading Activity
Healthcare • Medical Devices • 48,000 employees
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes; devices to treat urological conditions, including ureteral stents, catheters, baskets, guidewires, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, artificial urinary sphincter, laser system, fiber, and hydrogel systems; and devices to treat neurological movement disorders and manage chronic pain, such as spinal cord stimulator system, proprietary programming software, radiofrequency generator, indirect decompression systems, practice optimization tools, and deep brain stimulation system. It also provides technologies for diagnosing and treating coronary artery disease and aortic valve conditions; WATCHMAN FLX, a Left Atrial Appendage Closure Device; and implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities, such as cardioverter and cardiac resynchronization therapy defibrillators, MRI S-ICD systems, cardiac resynchronization therapy pacemakers, quadripolar LV leads, ICD leads, pacing leads, remote patient management systems, insertable cardiac monitor systems, and remote cardiac monitoring systems. In addition, the company offers diagnosis and treatment of rate and rhythm disorders of the heart; peripheral arterial and venous diseases; and products to diagnose, treat and ease forms of cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.
Total Value
-$82,768,478.94
Total Shares
5,929
Average Trade Value
-$481,212.09
Most Active Insider
Mahoney Michael F
Total Activity: $43,650,378
Largest Single Transaction
$13,573,743
by Mahoney Michael F on Nov 5, 2024
30-Day Activity
1 Transaction
Volume: 482 shares
Value: $50,432
Name
|
Position
|
Date
|
Shares
|
Value
|
Holdings
|
Type
|
---|---|---|---|---|---|---|
Svp, Global Controller and Cao
Officer
|
Mar 4, 2025 | 482 | $50,432 | 432 (-111.6%) | Sale | |
Svp, Global Controller and Cao
Officer
|
Mar 3, 2025 | 5,949 | $223,088 | 8,063 (+73.8%) | Exercise/Conversion | |
Svp, Global Controller and Cao
Officer
|
Mar 3, 2025 | 7,149 | $750,465 | 914 (-782.2%) | Sale | |
Svp, Global Controller and Cao
Officer
|
Mar 1, 2025 | 837 | $10,000 | 2,469 (+33.9%) | Exercise/Conversion | |
Svp, Global Controller and Cao
Officer
|
Mar 1, 2025 | 355 | $36,845 | 2,114 (-16.8%) | Payment of Exercise Price | |
Svp, Global Controller and Cao
Officer
|
Feb 28, 2025 | 7,218 | $304,311 | 11,519 (+62.7%) | Exercise/Conversion | |
Svp, Global Controller and Cao
Officer
|
Feb 28, 2025 | 9,887 | $999,872 | 1,632 (-605.8%) | Sale | |
Evppres, Periph Intervent
Officer
|
Feb 25, 2025 | 2,688 | $279,552 | 25,766 (-10.4%) | Sale | |
Director
|
Feb 24, 2025 | 13,586 | $1,416,134 | 34,944 (-38.9%) | Sale | |
Evppres, Periph Intervent
Officer
|
Feb 24, 2025 | 4,675 | $487,369 | 28,454 (-16.4%) | Sale | |
Svp, Gc and Corp. Secretary
Officer
|
Feb 21, 2025 | 4,826 | $504,993 | 45,845 (-10.5%) | Sale | |
EVP and CFO
Officer
|
Feb 19, 2025 | 16,865 | $291,090 | 268,016 (+6.3%) | Exercise/Conversion | |
EVP and CFO
Officer
|
Feb 19, 2025 | 67,333 | $7,086,111 | 225,808 (-29.8%) | Sale | |
EVP and CFO
Officer
|
Feb 19, 2025 | 15,642 | $423,742 | 283,658 (+5.5%) | Exercise/Conversion | |
Evp, Global Operations
Officer
|
Feb 19, 2025 | 3,303 | $347,443 | 20,991 (-15.7%) | Sale | |
Evppres, Periph Intervent
Officer
|
Feb 19, 2025 | 1,510 | $159,079 | 33,129 (-4.6%) | Sale | |
EVP and CFO
Officer
|
Feb 19, 2025 | 9,483 | $380,458 | 293,141 (+3.2%) | Exercise/Conversion | |
EVP and CFO
Officer
|
Feb 19, 2025 | 18,533 | $454,985 | 251,151 (+7.4%) | Exercise/Conversion | |
Evp, Global Operations
Officer
|
Feb 18, 2025 | 2,657 | $277,417 | 24,294 (-10.9%) | Sale | |
EVP and CFO
Officer
|
Feb 18, 2025 | 14,630 | $1,531,366 | 232,618 (-6.3%) | Sale | |
EVP and CFO
Officer
|
Feb 18, 2025 | 2,900 | $301,818 | 247,248 (-1.2%) | Sale | |
EVP Grp Pres, Medsurg Apac
Officer
|
Feb 17, 2025 | 1,315 | $139,535 | 22,235 (-5.9%) | Payment of Exercise Price | |
Evp, Global Operations
Officer
|
Feb 17, 2025 | 1,500 | $10,000 | 27,635 (+5.4%) | Exercise/Conversion | |
EVP and CFO
Officer
|
Feb 17, 2025 | 2,217 | $235,246 | 250,148 (-0.9%) | Payment of Exercise Price | |
EVP Group Pres, Cardiology
Officer
|
Feb 17, 2025 | 2,057 | $218,268 | 181,382 (-1.1%) | Payment of Exercise Price | |
Evppres, Periph Intervent
Officer
|
Feb 17, 2025 | 3,334 | $10,000 | 36,160 (+9.2%) | Exercise/Conversion | |
EVP Grp Pres, Medsurg Apac
Officer
|
Feb 17, 2025 | 2,834 | $10,000 | 23,550 (+12.0%) | Exercise/Conversion | |
Svp, Chief Hr Officer
Officer
|
Feb 17, 2025 | 100 | $10,000 | 1,767 (+5.7%) | Exercise/Conversion | |
Svp, Chief Hr Officer
Officer
|
Feb 17, 2025 | 294 | $31,196 | 14,777 (-2.0%) | Payment of Exercise Price | |
EVP and CFO
Officer
|
Feb 17, 2025 | 4,584 | $10,000 | 252,365 (+1.8%) | Exercise/Conversion | |
Svp, Gc and Corp. Secretary
Officer
|
Feb 17, 2025 | 484 | $51,357 | 50,671 (-1.0%) | Payment of Exercise Price | |
Evppres, Periph Intervent
Officer
|
Feb 17, 2025 | 1,521 | $161,393 | 34,639 (-4.4%) | Payment of Exercise Price | |
Svp, Chief Hr Officer
Officer
|
Feb 17, 2025 | 36 | $3,820 | 1,731 (-2.1%) | Payment of Exercise Price | |
Svp, Chief Hr Officer
Officer
|
Feb 17, 2025 | 1,000 | $10,000 | 15,071 (+6.6%) | Exercise/Conversion | |
Chairman, President CEO
Director, Officer
|
Feb 17, 2025 | 18,334 | $10,000 | 1,662,219 (+1.1%) | Exercise/Conversion | |
Svp, Gc and Corp. Secretary
Officer
|
Feb 17, 2025 | 1,000 | $10,000 | 51,155 (+2.0%) | Exercise/Conversion | |
Chairman, President CEO
Director, Officer
|
Feb 17, 2025 | 8,865 | $940,665 | 1,653,354 (-0.5%) | Payment of Exercise Price | |
EVP Group Pres, Cardiology
Officer
|
Feb 17, 2025 | 4,167 | $10,000 | 183,439 (+2.3%) | Exercise/Conversion | |
Evp, Global Operations
Officer
|
Feb 17, 2025 | 684 | $72,579 | 26,951 (-2.5%) | Payment of Exercise Price | |
Svp, Global Controller and Cao
Officer
|
Feb 17, 2025 | 283 | $30,029 | 4,301 (-6.6%) | Payment of Exercise Price | |
Svp, Global Controller and Cao
Officer
|
Feb 17, 2025 | 667 | $10,000 | 4,584 (+14.6%) | Exercise/Conversion | |
Svp, Gc and Corp. Secretary
Officer
|
Feb 16, 2025 | 1,839 | $10,000 | 51,045 (+3.6%) | Exercise/Conversion | |
Evppres, Periph Intervent
Officer
|
Feb 16, 2025 | 2,970 | $10,000 | 34,181 (+8.7%) | Exercise/Conversion | |
Chairman, President CEO
Director, Officer
|
Feb 16, 2025 | 7,865 | $834,555 | 1,643,885 (-0.5%) | Payment of Exercise Price | |
Chairman, President CEO
Director, Officer
|
Feb 16, 2025 | 16,265 | $10,000 | 1,651,750 (+1.0%) | Exercise/Conversion | |
Svp, Global Controller and Cao
Officer
|
Feb 16, 2025 | 636 | $10,000 | 4,188 (+15.2%) | Exercise/Conversion | |
Svp, Global Controller and Cao
Officer
|
Feb 16, 2025 | 271 | $28,756 | 3,917 (-6.9%) | Payment of Exercise Price | |
EVP and CFO
Officer
|
Feb 16, 2025 | 2,052 | $217,738 | 247,781 (-0.8%) | Payment of Exercise Price | |
EVP and CFO
Officer
|
Feb 16, 2025 | 4,243 | $10,000 | 249,833 (+1.7%) | Exercise/Conversion | |
Evppres, Periph Intervent
Officer
|
Feb 16, 2025 | 1,355 | $143,779 | 32,826 (-4.1%) | Payment of Exercise Price | |
EVP Group Pres, Cardiology
Officer
|
Feb 16, 2025 | 1,806 | $191,635 | 179,272 (-1.0%) | Payment of Exercise Price | |
EVP Grp Pres, Medsurg Apac
Officer
|
Feb 16, 2025 | 2,546 | $10,000 | 21,947 (+11.6%) | Exercise/Conversion | |
EVP Grp Pres, Medsurg Apac
Officer
|
Feb 16, 2025 | 1,231 | $130,621 | 20,716 (-5.9%) | Payment of Exercise Price | |
Evp, Global Operations
Officer
|
Feb 16, 2025 | 581 | $61,650 | 26,135 (-2.2%) | Payment of Exercise Price | |
Evp, Global Operations
Officer
|
Feb 16, 2025 | 1,273 | $0 | 26,716 (+4.8%) | Exercise/Conversion | |
EVP Group Pres, Cardiology
Officer
|
Feb 16, 2025 | 3,960 | $10,000 | 181,078 (+2.2%) | Exercise/Conversion | |
Svp, Chief Hr Officer
Officer
|
Feb 16, 2025 | 291 | $30,878 | 14,071 (-2.1%) | Payment of Exercise Price | |
Svp, Chief Hr Officer
Officer
|
Feb 16, 2025 | 990 | $10,000 | 14,362 (+6.9%) | Exercise/Conversion | |
Svp, Chief Hr Officer
Officer
|
Feb 16, 2025 | 85 | $10,000 | 1,697 (+5.0%) | Exercise/Conversion | |
Svp, Chief Hr Officer
Officer
|
Feb 16, 2025 | 30 | $3,183 | 1,667 (-1.8%) | Payment of Exercise Price | |
Svp, Gc and Corp. Secretary
Officer
|
Feb 16, 2025 | 890 | $94,438 | 50,155 (-1.8%) | Payment of Exercise Price | |
EVP Group Pres, Cardiology
Officer
|
Feb 14, 2025 | 1,990 | $211,159 | 177,118 (-1.1%) | Payment of Exercise Price | |
Svp, Global Controller and Cao
Officer
|
Feb 14, 2025 | 315 | $33,425 | 3,552 (-8.9%) | Payment of Exercise Price | |
Chairman, President CEO
Director, Officer
|
Feb 14, 2025 | 16,524 | $10,000 | 1,643,475 (+1.0%) | Exercise/Conversion | |
Chairman, President CEO
Director, Officer
|
Feb 14, 2025 | 7,990 | $847,819 | 1,635,485 (-0.5%) | Payment of Exercise Price | |
Svp, Chief Hr Officer
Officer
|
Feb 14, 2025 | 330 | $35,016 | 13,372 (-2.5%) | Payment of Exercise Price | |
EVP Grp Pres, Medsurg Apac
Officer
|
Feb 14, 2025 | 1,534 | $162,773 | 19,401 (-7.9%) | Payment of Exercise Price | |
Evppres, Periph Intervent
Officer
|
Feb 14, 2025 | 2,776 | $10,000 | 32,477 (+8.5%) | Exercise/Conversion | |
Svp, Chief Hr Officer
Officer
|
Feb 14, 2025 | 38 | $4,032 | 1,612 (-2.4%) | Payment of Exercise Price | |
EVP and CFO
Officer
|
Feb 14, 2025 | 4,362 | $10,000 | 247,700 (+1.8%) | Exercise/Conversion | |
Svp, Chief Hr Officer
Officer
|
Feb 14, 2025 | 1,123 | $10,000 | 13,702 (+8.2%) | Exercise/Conversion | |
Evppres, Periph Intervent
Officer
|
Feb 14, 2025 | 1,266 | $134,335 | 31,211 (-4.1%) | Payment of Exercise Price | |
Svp, Chief Hr Officer
Officer
|
Feb 14, 2025 | 106 | $10,000 | 1,650 (+6.4%) | Exercise/Conversion | |
EVP and CFO
Officer
|
Feb 14, 2025 | 2,110 | $223,892 | 245,590 (-0.9%) | Payment of Exercise Price | |
Evp, Global Operations
Officer
|
Feb 14, 2025 | 965 | $102,396 | 26,644 (-3.6%) | Payment of Exercise Price | |
Evp, Global Operations
Officer
|
Feb 14, 2025 | 1,201 | $127,678 | 25,443 (-4.7%) | Sale | |
Svp, Gc and Corp. Secretary
Officer
|
Feb 14, 2025 | 895 | $94,968 | 49,206 (-1.8%) | Payment of Exercise Price | |
Evp, Global Operations
Officer
|
Feb 14, 2025 | 2,115 | $10,000 | 27,609 (+7.7%) | Exercise/Conversion | |
EVP Group Pres, Cardiology
Officer
|
Feb 14, 2025 | 4,362 | $0 | 179,108 (+2.4%) | Exercise/Conversion | |
Svp, Gc and Corp. Secretary
Officer
|
Feb 14, 2025 | 1,850 | $10,000 | 50,101 (+3.7%) | Exercise/Conversion | |
EVP Grp Pres, Medsurg Apac
Officer
|
Feb 14, 2025 | 3,172 | $10,000 | 20,935 (+15.2%) | Exercise/Conversion | |
Svp, Global Controller and Cao
Officer
|
Feb 14, 2025 | 661 | $10,000 | 3,867 (+17.1%) | Exercise/Conversion | |
EVP Grp Pres, Medsurg Apac
Officer
|
Feb 12, 2025 | 950 | $100,482 | 17,763 (-5.3%) | Payment of Exercise Price | |
EVP Group Pres, Cardiology
Officer
|
Feb 12, 2025 | 1,579 | $167,011 | 174,746 (-0.9%) | Payment of Exercise Price | |
EVP Group Pres, Cardiology
Officer
|
Feb 12, 2025 | 3,462 | $10,000 | 176,325 (+2.0%) | Exercise/Conversion | |
Evppres, Periph Intervent
Officer
|
Feb 12, 2025 | 868 | $91,808 | 29,701 (-2.9%) | Payment of Exercise Price | |
Evppres, Periph Intervent
Officer
|
Feb 12, 2025 | 2,115 | $10,000 | 30,569 (+6.9%) | Exercise/Conversion | |
Svp, Chief Hr Officer
Officer
|
Feb 12, 2025 | 338 | $35,750 | 12,579 (-2.7%) | Payment of Exercise Price | |
Svp, Global Controller and Cao
Officer
|
Feb 12, 2025 | 480 | $10,000 | 3,437 (+14.0%) | Exercise/Conversion | |
Svp, Global Controller and Cao
Officer
|
Feb 12, 2025 | 231 | $24,433 | 3,206 (-7.2%) | Payment of Exercise Price | |
Svp, Chief Hr Officer
Officer
|
Feb 12, 2025 | 23 | $2,433 | 1,544 (-1.5%) | Payment of Exercise Price | |
Svp, Chief Hr Officer
Officer
|
Feb 12, 2025 | 961 | $10,000 | 12,917 (+7.4%) | Exercise/Conversion | |
Svp, Chief Hr Officer
Officer
|
Feb 12, 2025 | 65 | $10,000 | 1,567 (+4.1%) | Exercise/Conversion | |
Chairman, President CEO
Director, Officer
|
Feb 12, 2025 | 13,704 | $10,000 | 1,633,577 (+0.8%) | Exercise/Conversion | |
Chairman, President CEO
Director, Officer
|
Feb 12, 2025 | 6,626 | $700,832 | 1,626,951 (-0.4%) | Payment of Exercise Price | |
EVP and CFO
Officer
|
Feb 12, 2025 | 3,654 | $10,000 | 245,105 (+1.5%) | Exercise/Conversion | |
EVP and CFO
Officer
|
Feb 12, 2025 | 1,767 | $186,896 | 243,338 (-0.7%) | Payment of Exercise Price | |
Evppres, Periph Intervent
Officer
|
Feb 12, 2025 | 13,022 | $1,368,073 | 28,454 (-45.8%) | Sale | |
EVP and CFO
Officer
|
Feb 12, 2025 | 15,087 | $246,069 | 256,538 (+5.9%) | Exercise/Conversion | |
EVP and CFO
Officer
|
Feb 12, 2025 | 15,087 | $1,585,135 | 241,451 (-6.2%) | Sale | |
Evp, Global Operations
Officer
|
Feb 12, 2025 | 6,389 | $671,249 | 24,293 (-26.3%) | Sale | |
Evp, Global Operations
Officer
|
Feb 12, 2025 | 530 | $56,058 | 25,494 (-2.1%) | Payment of Exercise Price | |
EVP Grp Pres, Medsurg Apac
Officer
|
Feb 12, 2025 | 2,692 | $10,000 | 18,713 (+14.4%) | Exercise/Conversion | |
Svp, Gc and Corp. Secretary
Officer
|
Feb 12, 2025 | 424 | $44,846 | 48,251 (-0.9%) | Payment of Exercise Price | |
Evp, Global Operations
Officer
|
Feb 12, 2025 | 1,731 | $10,000 | 26,024 (+6.7%) | Exercise/Conversion | |
Svp, Gc and Corp. Secretary
Officer
|
Feb 12, 2025 | 1,442 | $10,000 | 48,675 (+3.0%) | Exercise/Conversion | |
EVP Grp Pres, Medsurg Apac
Officer
|
Feb 11, 2025 | 9,847 | $1,043,585 | 16,021 (-61.5%) | Payment of Exercise Price | |
Evp, Global Operations
Officer
|
Feb 11, 2025 | 3,793 | $401,982 | 32,838 (-11.6%) | Payment of Exercise Price | |
EVP and CFO
Officer
|
Feb 11, 2025 | 16,414 | $1,739,556 | 241,451 (-6.8%) | Payment of Exercise Price | |
EVP Grp Pres, Medsurg Apac
Officer
|
Feb 11, 2025 | 20,366 | $0 | 25,868 (+78.7%) | Grant | |
Director
|
Feb 11, 2025 | 12,000 | $1,265,815 | 24,398 (-49.2%) | Sale | |
Evp, Global Operations
Officer
|
Feb 11, 2025 | 10,182 | $0 | 36,631 (+27.8%) | Grant | |
EVP and CFO
Officer
|
Feb 11, 2025 | 33,944 | $0 | 257,865 (+13.2%) | Grant | |
EVP Group Pres, Cardiology
Officer
|
Feb 11, 2025 | 31,680 | $0 | 187,310 (+16.9%) | Grant | |
EVP Group Pres, Cardiology
Officer
|
Feb 11, 2025 | 14,447 | $1,531,093 | 172,863 (-8.4%) | Payment of Exercise Price | |
Svp, Gc and Corp. Secretary
Officer
|
Feb 11, 2025 | 6,350 | $672,973 | 47,233 (-13.4%) | Payment of Exercise Price | |
Svp, Gc and Corp. Secretary
Officer
|
Feb 11, 2025 | 14,708 | $0 | 53,583 (+27.4%) | Grant | |
Chairman, President CEO
Director, Officer
|
Feb 11, 2025 | 130,118 | $0 | 1,682,788 (+7.7%) | Grant | |
Chairman, President CEO
Director, Officer
|
Feb 11, 2025 | 62,915 | $6,667,732 | 1,619,873 (-3.9%) | Payment of Exercise Price | |
Evppres, Periph Intervent
Officer
|
Feb 11, 2025 | 23,760 | $0 | 52,214 (+45.5%) | Grant | |
Evppres, Periph Intervent
Officer
|
Feb 11, 2025 | 10,738 | $1,138,013 | 41,476 (-25.9%) | Payment of Exercise Price | |
Evp, Global Operations
Officer
|
Feb 7, 2025 | 6,528 | $685,244 | 26,449 (-24.7%) | Sale | |
EVP Grp Pres, Medsurg Apac
Officer
|
Feb 3, 2025 | 1,009 | $17,415 | 22,815 (+4.4%) | Exercise/Conversion | |
EVP Grp Pres, Medsurg Apac
Officer
|
Feb 3, 2025 | 8,508 | $863,169 | 14,307 (-59.5%) | Sale | |
EVP Grp Pres, Medsurg Apac
Officer
|
Feb 3, 2025 | 8,805 | $899,338 | 5,502 (-160.0%) | Sale | |
EVP Grp Pres, Medsurg Apac
Officer
|
Feb 3, 2025 | 6,952 | $188,330 | 12,454 (+55.8%) | Exercise/Conversion | |
EVP Grp Pres, Medsurg Apac
Officer
|
Feb 3, 2025 | 3,176 | $72,127 | 21,806 (+14.6%) | Exercise/Conversion | |
EVP Grp Pres, Medsurg Apac
Officer
|
Feb 3, 2025 | 6,176 | $151,621 | 18,630 (+33.2%) | Exercise/Conversion | |
Evp, Global Operations
Officer
|
Jan 3, 2025 | 2,342 | $210,449 | 32,977 (-7.1%) | Sale | |
EVP and CFO
Officer
|
Jan 3, 2025 | 9,689 | $870,636 | 223,921 (-4.3%) | Sale | |
Evppres, Periph Intervent
Officer
|
Jan 3, 2025 | 7,152 | $642,658 | 28,454 (-25.1%) | Sale | |
Evp, Global Operations
Officer
|
Jan 2, 2025 | 4,119 | $370,792 | 35,319 (-11.7%) | Sale | |
Chairman, President CEO
Director, Officer
|
Jan 1, 2025 | 57,121 | $0 | 1,578,326 (+3.6%) | Exercise/Conversion | |
Evp, Global Operations
Officer
|
Jan 1, 2025 | 2,127 | $189,984 | 39,438 (-5.4%) | Payment of Exercise Price | |
Evp, Global Operations
Officer
|
Jan 1, 2025 | 4,469 | $0 | 41,565 (+10.8%) | Exercise/Conversion | |
EVP Group Pres, Cardiology
Officer
|
Jan 1, 2025 | 13,907 | $0 | 162,025 (+8.6%) | Exercise/Conversion | |
EVP Group Pres, Cardiology
Officer
|
Jan 1, 2025 | 6,425 | $573,881 | 155,600 (-4.1%) | Payment of Exercise Price | |
Evppres, Periph Intervent
Officer
|
Jan 1, 2025 | 10,430 | $0 | 38,884 (+26.8%) | Exercise/Conversion | |
Evppres, Periph Intervent
Officer
|
Jan 1, 2025 | 3,278 | $292,791 | 35,606 (-9.2%) | Payment of Exercise Price | |
Svp, Gc and Corp. Secretary
Officer
|
Jan 1, 2025 | 6,456 | $0 | 40,866 (+15.8%) | Exercise/Conversion | |
Svp, Gc and Corp. Secretary
Officer
|
Jan 1, 2025 | 1,991 | $177,836 | 38,875 (-5.1%) | Payment of Exercise Price | |
EVP and CFO
Officer
|
Jan 1, 2025 | 14,901 | $0 | 238,822 (+6.2%) | Exercise/Conversion | |
EVP and CFO
Officer
|
Jan 1, 2025 | 5,212 | $465,536 | 233,610 (-2.2%) | Payment of Exercise Price | |
EVP Grp Pres, Medsurg Apac
Officer
|
Jan 1, 2025 | 8,940 | $0 | 9,918 (+90.1%) | Exercise/Conversion | |
EVP Grp Pres, Medsurg Apac
Officer
|
Jan 1, 2025 | 4,416 | $394,437 | 5,502 (-80.3%) | Payment of Exercise Price | |
Chairman, President CEO
Director, Officer
|
Jan 1, 2025 | 25,656 | $2,291,594 | 1,552,670 (-1.7%) | Payment of Exercise Price | |
EVP Group Pres, Cardiology
Officer
|
Dec 10, 2024 | 20 | $1,799 | 148,148 (-0.0%) | Sale | |
EVP Group Pres, Cardiology
Officer
|
Dec 3, 2024 | 50 | $4,515 | 148,168 (+0.0%) | Purchase | |
Evp, Human Resources
Officer
|
Dec 2, 2024 | 1,197 | $29,386 | 36,291 (+3.3%) | Exercise/Conversion | |
Evp, Human Resources
Officer
|
Dec 2, 2024 | 3,066 | $52,919 | 35,094 (+8.7%) | Exercise/Conversion | |
Evp, Human Resources
Officer
|
Dec 2, 2024 | 6,983 | $633,917 | 29,308 (-23.8%) | Sale | |
Svp, Global Controller and Cao
Officer
|
Nov 27, 2024 | 1,336 | $121,105 | 2,957 (-45.2%) | Sale | |
EVP Grp Pres, Medsurg Apac
Officer
|
Nov 25, 2024 | 14,010 | $1,250,664 | 978 (-1432.5%) | Sale | |
EVP Grp Pres, Medsurg Apac
Officer
|
Nov 25, 2024 | 3,177 | $72,150 | 13,979 (+22.7%) | Exercise/Conversion | |
EVP Grp Pres, Medsurg Apac
Officer
|
Nov 25, 2024 | 1,009 | $17,415 | 14,988 (+6.7%) | Exercise/Conversion | |
Director
|
Nov 21, 2024 | 4,877 | $446,902 | 39,398 (-12.4%) | Sale | |
Evp, Global Operations
Officer
|
Nov 8, 2024 | 17,362 | $426,237 | 70,286 (+24.7%) | Exercise/Conversion | |
Evp, Global Operations
Officer
|
Nov 8, 2024 | 30,580 | $2,680,572 | 39,706 (-77.0%) | Sale | |
Chairman, President CEO
Director, Officer
|
Nov 5, 2024 | 56,211 | $970,202 | 1,628,307 (+3.5%) | Exercise/Conversion | |
Chairman, President CEO
Director, Officer
|
Nov 5, 2024 | 2,596 | $221,108 | 1,681,387 (-0.2%) | Sale | |
Chairman, President CEO
Director, Officer
|
Nov 5, 2024 | 55,676 | $908,076 | 1,683,983 (+3.3%) | Exercise/Conversion | |
Chairman, President CEO
Director, Officer
|
Nov 5, 2024 | 160,182 | $13,573,743 | 1,521,205 (-10.5%) | Sale | |
Evp, Human Resources
Officer
|
Nov 1, 2024 | 1,197 | $29,386 | 39,011 (+3.1%) | Exercise/Conversion | |
Evp, Human Resources
Officer
|
Nov 1, 2024 | 3,066 | $52,919 | 37,814 (+8.1%) | Exercise/Conversion | |
Evp, Human Resources
Officer
|
Nov 1, 2024 | 6,983 | $588,876 | 32,028 (-21.8%) | Sale | |
EVP Group Pres, Cardiology
Officer
|
Oct 7, 2024 | 59,021 | $1,018,702 | 235,376 (+25.1%) | Exercise/Conversion | |
EVP Group Pres, Cardiology
Officer
|
Oct 7, 2024 | 132,527 | $11,264,888 | 160,467 (-82.6%) | Sale | |
Chairman, President CEO
Director, Officer
|
Oct 7, 2024 | 82,085 | $6,972,431 | 1,572,096 (-5.2%) | Sale | |
Chairman, President CEO
Director, Officer
|
Oct 7, 2024 | 80,692 | $6,803,360 | 1,654,181 (-4.9%) | Sale | |
Chairman, President CEO
Director, Officer
|
Oct 7, 2024 | 55,675 | $908,059 | 1,734,873 (+3.2%) | Exercise/Conversion | |
EVP Group Pres, Cardiology
Officer
|
Oct 7, 2024 | 57,618 | $1,439,298 | 292,994 (+19.7%) | Exercise/Conversion | |
Chairman, President CEO
Director, Officer
|
Oct 7, 2024 | 56,211 | $970,202 | 1,679,198 (+3.3%) | Exercise/Conversion |